Allorion Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.alloriontx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Allorion Therapeutics Inc
- Target Recruit Count
- 76
- Registration Number
- NCT06260527
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
News
No news found